UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012063 |
|---|---|
| Receipt number | R000014103 |
| Scientific Title | Multicenter Phase II study of combination therapy with S-1 plus Irinotecan plus Cetuximab (MetronomicIRIS/Cmab combination therapy) in patients with KRAS wild type unresectable colorectal cancer, who had previously received on fluoropyrimidine , oxaliplatin , irinotecan and bevacizumab. (KSCOG CR-06) |
| Date of disclosure of the study information | 2013/10/18 |
| Last modified on | 2016/10/28 13:52:43 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/10/17 19:53:53 | ||
| 2 | Update | 2016/10/28 13:52:44 | Recruitment status Last follow-up date Date of closure to data entry |
